...catalysts coming in Q3 and Q4. Four data releases and one big meeting with the FDA.
It appears ONCS is gathering on the launch pad readying it's self.
Yep.....the biggest one I believe is the meeting with the FDA. But first we need outstanding trial results, otherwise the meeting is moot.